Novo Nordisk (NVO) Upgraded to Strong Buy: What Does It Mean for the Stock?Zacks Investment Research • 01/18/24
Ozempic has transformed Novo Nordisk, but who is next with a me-too weight loss drug?Proactive Investors • 01/15/24
Have Novo Nordisk shares got further to go? This investment bank has its sayProactive Investors • 01/15/24
After Surging 53% in 2023, This Pharmaceutical Stock Might Be About to Crash. Here's Why I'm Probably WrongThe Motley Fool • 01/13/24
Should You Invest in Novo Nordisk (NVO) Based on Bullish Wall Street Views?Zacks Investment Research • 01/12/24
What is Wegovy worth to your employer? Companies wrestle with obesity drugs' costs, long-term value.Market Watch • 01/10/24
Novo Nordisk A/S (NVO) Presents at J.P. Morgan 42nd Annual Healthcare Conference TranscriptSeeking Alpha • 01/09/24
Dow Jones Leader Amgen Extends Gains Past Buy Point; Ozempic Maker Novo Nordisk Breaks OutInvestors Business Daily • 01/08/24